Omeros (OMER) Long-Term Investments (2015 - 2018)
Omeros (OMER) reported Long-Term Investments of $1.2 million for Q4 2018, down 80.22% on a YoY basis from $5.8 million in Q4 2017, and down 80.22% sequentially from $5.8 million in Q4 2017.
Omeros (OMER) Long-Term Investments (2015 - 2018) Analysis & Trends
Omeros (OMER) has 4 years of Long-Term Investments data on file, last reported at $1.2 million in Q4 2018.
- For the quarter ending Q4 2018, Long-Term Investments fell 80.22% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2018 stood at $1.2 million (down 80.22% YoY), and the FY2018 full-year result was $1.2 million, down 80.22% from the prior year.
- Long-Term Investments eased to $1.2 million in Q4 2018, from $5.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $10.7 million in Q4 2015 to a low of $1.2 million in Q4 2018.
- A 4-year average of $5.9 million and a median of $5.8 million in 2016 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments changed 0.0% in 2017 and plunged 80.22% in 2018, its largest moves.
- Tracing OMER's Long-Term Investments over 4 years: stood at $10.7 million in 2015, then tumbled by 45.36% to $5.8 million in 2016, then changed by 0.0% to $5.8 million in 2017, then slumped by 80.22% to $1.2 million in 2018.
- Business Quant data shows OMER's Long-Term Investments at $1.2 million in Q4 2018, $5.8 million in Q4 2017, and $5.8 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 5.84 Mn |
| Dec 31, 2016 | 5.84 Mn |
| Dec 31, 2015 | 10.68 Mn |